Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group (Q46619788)
Jump to navigation
Jump to search
scientific article published in May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group |
scientific article published in May 2008 |
Statements
1 reference
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group (English)
1 reference
F Stephen Hodi
1 reference
David F McDermott
1 reference
Jeffrey A Sosman
1 reference
Rene Gonzalez
1 reference
Gerald P Linette
1 reference
Jon Richards
1 reference
James W Jakub
1 reference
Muralidhar Beeram
1 reference
Stefano Tarantolo
1 reference
Sanjiv Agarwala
1 reference
Gary Frenette
1 reference
Igor Puzanov
1 reference
Lee Cranmer
1 reference
Karl Lewis
1 reference
John Kirkwood
1 reference
J Michael White
1 reference
Chenghua Xia
1 reference
Kiran Patel
1 reference
Evan Hersh
1 reference
1 May 2008
1 reference
26
1 reference
13
1 reference
2178-2185
1 reference
1 reference